Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Immunomedics Reports Preliminary Results From Pretargeted Imaging Study in Patients With Metastatic Breast Cancer

GlobeNewswire December 15, 2014

Biocept Expands Worldwide Microchannel Patent Protection to South Korea

GlobeNewswire December 15, 2014

Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutics

Business Wire December 15, 2014

AppDirect Wins Cloud Asia Award for Best Cloud Platform

Business Wire December 15, 2014

Enanta Pharmaceuticals Added to the NASDAQ Biotechnology Index

Business Wire December 15, 2014

Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index

Business Wire December 15, 2014

Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product

PR Newswire December 15, 2014

Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director

GlobeNewswire December 15, 2014

Cancer Treatment Centers of America Selects WIRB-Copernicus Group to Facilitate the Expansion of its Clinical Research Program

PR Newswire December 15, 2014

Macrocure Ltd. Featured in Five News Outlets

GlobeNewswire December 15, 2014

Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results

GlobeNewswire December 15, 2014

Adjuvantz Adopts Symbility Health's Claims Connect Platform

Marketwired December 15, 2014

AppDynamics Joins Cloud Foundry Foundation to Define Standards for Platform-as-a-Service

Marketwired December 15, 2014

OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP)

Business Wire December 15, 2014

Acceleron Pharma Added to NASDAQ Biotechnology Index

Business Wire December 15, 2014

WuXi Opening Offices in Boston and San Francisco

PR Newswire December 15, 2014

Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors

Canada NewsWire December 15, 2014

Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index

PR Newswire December 15, 2014

Akebia Therapeutics, Inc. Added to NASDAQ Biotechnology Index

Business Wire December 15, 2014

PCT, a NeoStem Company, Presented Lovo(R) Cell Processing System Data at IBC Life Sciences' Commercialization of Cell, Gene & Immunotherapies Conference

GlobeNewswire December 15, 2014